Skip to main content

Table 4 Operative details: the bypass data were compatible

From: Is there a renoprotective value to leukodepletion during heart valve surgery? A randomized controlled trial (ROLO)

Operation detail   Randomized to leukodepletion filter (n = 32) Randomized to standard
filter (n = 31)
Overall
(n = 63)
n % n % n %
Type of surgery Valve 15/31a 48% 18/31 58% 33/62 53%
CABG and valve 11/31a 35% 10/31 32% 21/62 34%
Valve and other 5/31a 16% 3/31 10% 8/62 13%
Valve replacement   26/31a 84% 25/31 81% 51/62 82%
Valve repair   8/31a 26% 7/31 23% 15/62 24%
Valve Replacement Details Aortic 23/26 88% 24/25 96% 47/51 92%
Mitral 3/26 12% 1/25 4% 4/51 8%
Valve Repair Details Mitral 4/8 50% 5/7 71% 9/15 60%
Tricuspid 3/8 38% 2/7 29% 5/15 33%
Pulmonary 1/8 13% 0/7 0% 1/15 7%
BYPASS DATA
Total CPB duration (minutes) Median (IQR) 119.0 (97.0, 151.0) 124.0 (107.0, 141.0) 123.5 (99.0, 146.0)
  1. Details on missing data (Leukodepletion, Standard): (1, 0)
  2. IQR interquartile
  3. a1 patient in the leukodepletion filter group was missing CPB specific data, as this patient was an open and shut case